Angioimmunoblastic T-cell lymphoma refractory – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:13:58 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Angioimmunoblastic T-cell lymphoma refractory – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness and Safety of Azacitidine, Gemcitabine, and Bendamustine Hydrochloride for Patients with Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-azacitidine-gemcitabine-and-bendamustine-hydrochloride-for-patients-with-relapsed-or-refractory-angioimmunoblastic-t-cell-lymphoma/ Wed, 29 Apr 2026 15:02:33 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-azacitidine-gemcitabine-and-bendamustine-hydrochloride-for-patients-with-relapsed-or-refractory-angioimmunoblastic-t-cell-lymphoma/ This clinical trial is focused on studying a type of cancer called Angioimmunoblastic T-cell Lymphoma, which is a rare form of non-Hodgkin lymphoma. The study is investigating the effectiveness and safety of a medication called Azacitidine, which is taken orally in the form of a tablet. The trial compares this treatment to other therapies chosen by the doctors involved in the study. The purpose of the study is to see how well patients do without their disease getting worse.

Participants in the study will receive either Azacitidine or another treatment selected by their doctor. The study will monitor the patients over a period to see how the disease responds to the treatment. The trial will also look at how long patients live overall and how their quality of life is affected by the treatment. The study aims to provide more information on the best treatment options for patients with this type of lymphoma.

Other medications involved in the study include Gemcitabine and Bendamustine Hydrochloride, which are given through infusion, meaning they are administered directly into the bloodstream. The study will help determine if Azacitidine is a better option compared to these and other treatments. Participants will be closely monitored by healthcare professionals throughout the study to ensure their safety and to gather important data on the treatment’s effects.

]]>